Low bone mineral density in adolescents with leukemia after hematopoietic stem cell transplantation: prolonged steroid therapy for GvHD and endocrinopathy after hematopoietic stem cell transplantation might be major concerns?

Cho, W K; Ahn, M B; Lee, J-W; Chung, N-G; Jung, M H; Cho, B; Suh, B-K
Bone marrow transplantation
2017Jan ; 52 ( 1 ) :144-146.
PMID : 27479687
ÀúÀÚ »ó¼¼Á¤º¸
Cho, W K -
Ahn, M B -
Lee, J-W -
Chung, N-G -
Jung, M H -
Cho, B -
Suh, B-K -
ABSTRACT
na
¸µÅ©

ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Å°¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
One-third of adolescents with leukemia treated with HSCT showed low bone mineral density (BMD).
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆdz⵵(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
DOI
10.1038/bmt.2016.199.
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå